Ignite Creation Date:
2025-12-24 @ 2:21 PM
Ignite Modification Date:
2026-01-21 @ 1:59 PM
Study NCT ID:
NCT04348695
Status:
COMPLETED
Last Update Posted:
2022-06-06
First Post:
2020-04-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.
Sponsor:
Fundación de investigación HM
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Ruxo-Sim-20
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |